Evidence Sources
Browse 14344 of 14344 research sources from PubMed and clinical trials (page 24 of 287)
Filter by source class:
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.
2025
Guideline
· PMID: 40947910
· DOI: 10.1177/03008916251367339
· PMID: 40952529
· DOI: 10.1007/s10822-025-00657-6
· PMID: 40953975
· DOI: 10.3760/cma.j.cn112137-20250417-00951
· PMID: 40957230
· DOI: 10.1016/j.clnu.2025.08.029
· PMID: 40958473
· DOI: 10.3760/cma.j.cn112137-20250321-00695
[Expert consensus on the application of intravenous immunoglobulin in children with autoimmune neurological disorders (2025)].
2025
Guideline
· PMID: 40962535
· DOI: 10.3760/cma.j.cn112140-20250704-00580
Iraqi consensus recommendations for the diagnosis and management of immune thrombocytopenia.
2025
Guideline
· PMID: 40963253
· DOI: 10.1080/16078454.2025.2555045
· PMID: 40967038
· DOI: 10.1016/j.pediatrneurol.2025.08.010
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC.
2025
Guideline
· PMID: 40967134
· DOI: 10.1016/j.lungcan.2025.108717
[Expert consensus on diagnosis and treatment of advanced non-small cell lung cancer with HER-2 alterations (2025 edition)].
2025
Guideline
· PMID: 40967873
· DOI: 10.3760/cma.j.cn112152-20250414-00163
· PMID: 40971372
· DOI: 10.1371/journal.pone.0332413
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.
2025
Guideline
· PMID: 40974042
· DOI: 10.1002/cpt.70071
· PMID: 40975525
· DOI: 10.1016/j.kint.2025.04.003
A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection.
2025
Guideline
· PMID: 40985996
· DOI: 10.1002/hon.70125
Improving thermostability of α-L-fucosidase from Pedobacter sp. via consensus-guided engineering and directed evolution.
2025
Guideline
· PMID: 40992629
· DOI: 10.1016/j.jbiotec.2025.09.011
· PMID: 40996820
· DOI: 10.20344/amp.23610
Merging conformational landscapes in a single consensus space with FlexConsensus algorithm.
2025
Guideline
· PMID: 40999098
· DOI: 10.1038/s41592-025-02841-w
· PMID: 40999951
· DOI: 10.1002/ueg2.70119
· PMID: 41002085
[Hereditary genetic testing and its application in the diagnosis, treatment, and prevention of breast cancer].
2025
Guideline
· PMID: 41002090
· PMID: 41003812
· DOI: 10.1007/s10142-025-01691-1
· PMID: 41017594
· DOI: 10.1177/03008916251379317
Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.
2025
Guideline
· PMID: 41020749
· DOI: 10.1016/j.jacc.2025.08.047
Diagnosis of Alzheimer's disease: Recommendations from the French Federation of Memory Clinics.
2025
Guideline
· PMID: 41033931
· DOI: 10.1016/j.neurol.2025.09.004
[New diagnostic criteria 2024 for multiple sclerosis].
2025
Guideline
· PMID: 41036984
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase.
2025
Guideline
· PMID: 41054963
· DOI: 10.1080/16078454.2025.2556506
· PMID: 41057128
· DOI: 10.1016/j.critrevonc.2025.104978
[Management of ectopic pregnancies: therapeutic options and clinical decision-making criteria].
2025
Guideline
· PMID: 41069289
British Dietetic Association Guidelines for the Dietary Management of Chronic Constipation in Adults.
2025
Guideline
· PMID: 41081381
· DOI: 10.1111/nmo.70173
[Clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)].
2025
Guideline
· PMID: 41083387
· DOI: 10.3760/cma.j.cn112138-20250707-00396
Latin America Multidisciplinary Consensus Panel on Management of Severe Bleeding in the Anticoagulated Patient.
2025
Guideline
· PMID: 41086561
· DOI: 10.1016/j.jemermed.2025.04.010
[Chinese guidelines on the treatment of hemophilia (2025)].
2025
Guideline
· PMID: 41087175
· DOI: 10.3760/cma.j.cn121090-20250729-00354
Computational analysis reveals non-consensus N-glycosylation sequons in antibody Fab region.
2025
Guideline
· PMID: 41090251
· DOI: 10.1080/19420862.2025.2574406
Expanding the HP1a-binding consensus and molecular grammar for heterochromatin assembly.
2025
Guideline
· PMID: 41099702
· DOI: 10.1093/nar/gkaf976
· PMID: 41107965
· DOI: 10.1186/s13023-025-04047-x
· PMID: 41110921
· DOI: 10.1016/j.cjca.2025.07.027
· PMID: 41110922
· DOI: 10.1016/j.cjca.2025.05.019
· PMID: 41111054
· DOI: 10.1016/j.endien.2025.501639
[Physical training for fracture prevention : Evidence- and consensus-based practice recommendations of the updated DVO guideline].
2025
Guideline
· PMID: 41136768
· DOI: 10.1007/s00132-025-04731-7
[Chinese expert consensus on the evaluation of allergen-specific immunotherapy outcomes（Wuhan, 2025）].
2025
Guideline
· PMID: 41147184
· DOI: 10.13201/j.issn.2096-7993.2025.11.015
[KDIGO-Update: Treatment of ANCA vasculitis].
2025
Guideline
· PMID: 41151615
· DOI: 10.1055/a-2502-1480
Integrated machine learning survival framework for consensus modeling in a large multicenter cohort of NSCLC resistant to aumolertinib.
2025
Guideline
· PMID: 41152375
· DOI: 10.1038/s41598-025-20159-7
Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
2025
Guideline
· PMID: 41155498
· DOI: 10.3390/ijms262010207
[Chinese expert consensus on clinical practice of chronic hepatitis B functional (clinical) cure].
2025
Guideline
· PMID: 41167769
· DOI: 10.3760/cma.j.cn501113-20250723-00286
· PMID: 41167770
· DOI: 10.3760/cma.j.cn501113-20250408-00130
· PMID: 41168057
· DOI: 10.1016/j.revmed.2025.09.005
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panel.
2025
Guideline
· PMID: 41171785
· DOI: 10.25251/tvshr813
How Janus kinase selectivity impacts efficacy and safety of abrocitinib for atopic dermatitis: an expert consensus panel.
2025
Guideline
· PMID: 41171808
· DOI: 10.25251/wfz5mg56
· PMID: 41171810
· DOI: 10.25251/s3cn8t86
[Expert consensus on folate receptor α immunohistochemical testing in ovarian cancer and its clinical applications (2025 version)].
2025
Guideline
· PMID: 41183813
· DOI: 10.3760/cma.j.cn112151-20250806-00540